Established breast cancer risk factors by clinically important tumour characteristics
Open Access
- 6 June 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 95 (1), 123-129
- https://doi.org/10.1038/sj.bjc.6603207
Abstract
Breast cancer is a morphologically and clinically heterogeneous disease; however, it is less clear how risk factors relate to tumour features. We evaluated risk factors by tumour characteristics (histopathologic type, grade, size, and nodal status) in a population-based case–control of 2386 breast cancers and 2502 controls in Poland. Use of a novel extension of the polytomous logistic regression permitted simultaneous modelling of multiple tumour characteristics. Late age at first full-term birth was associated with increased risk of large (>2 cm) tumours (odds ratios (95% confidence intervals) 1.19 (1.07–1.33) for a 5-year increase in age), but not smaller tumours (P for heterogeneity adjusting for other tumour features (Phet)=0.007). On the other hand, multiparity was associated with reduced risk for small tumours (0.76 (0.68–0.86) per additional birth; Phet=0.004). Consideration of all tumour characteristics simultaneously revealed that current or recent use of combined hormone replacement therapy was associated with risk of small (2.29 (1.66–3.15)) and grade 1 (3.36 (2.22–5.08)) tumours (Phet=0.05 for size and 0.0008 for grade 1 vs 3), rather than specific histopathologic types (Phet=0.63 for ductal vs lobular). Finally, elevated body mass index was associated with larger tumour size among both pre- and postmenopausal women (Phet=0.05 and 0.0001, respectively). None of these relationships were explained by hormone receptor status of the tumours. In conclusion, these data support distinctive risk factor relationships by tumour characteristics of prognostic relevance. These findings might be useful in developing targeted prevention efforts.Keywords
This publication has 38 references indexed in Scilit:
- Distinct breast cancer incidence and prognostic patterns in the NCI?s SEER program: suggesting a possible link between etiology and outcomeBreast Cancer Research and Treatment, 2005
- Stable ‘portrait’ of breast tumors during progression: data from biology, pathology and geneticsEndocrine-Related Cancer, 2004
- A Two-Stage Regression Model for Epidemiological Studies With Multivariate Disease Classification DataJournal of the American Statistical Association, 2004
- Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinomaCancer, 2002
- Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapyInternational Journal of Cancer, 2001
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Histologic types of breast carcinoma in relation to international variation and breast cancer risk factorsInternational Journal of Cancer, 1989
- Body weight, serum cholesterol, and stage of primary breast cancerCancer, 1986
- Tubular carcinoma: a variant of secretory breast carcinomaHistopathology, 1979
- Histologic specificity of the effect of age at birth of first child on breast cancer riskInternational Journal of Cancer, 1976